Adrian Jacques H. Ambrose

System-based barriers in healthcare for vulnerable and marginalized communities; structural and ethical factors in technological development; artificial intelligence and digital therapeutics; health inequity.

Adrian Jacques H. Ambrose is the Chief Clinical Integration Officer for the Department of Psychiatry at Columbia University Medical Center and Senior Medical Director at ColumbiaDoctors Psychiatry. Integrating business development with clinical medicine, he also previously served as a subspecialist consultant in team engagement and strategy for healthcare industries through the MassGeneral BrighamConnected Health, Massachusetts General Hospital / Harvard Medical School. For over a decade, Dr Ambrose has also served as a senior consultant in designing national and global programming for system change management, wellness and burnout, DEI/ESG assessment and operations for industry, including Fortune 100 companies. In addition, he specializes in cultivating psychological safety, team building, and culture acceleration for senior managers and executives.

Clinically, Dr Ambrose specializes in treatment-refractory mood disorders for both the adult and child and adolescent populations in interventional psychiatry and novel therapeutics, such as, neuronavigated transcranial magnetic stimulation, rapid acting racemic ketamine & esketamine, and entactogen-assisted psychotherapy. He also regularly sees executives with high functioning anxiety. Ambrose completed his clinical trainings at Dartmouth Hitchcock Medical Center and Massachusetts General Hospital/McLean Hospital, public health training at the National Center for Primary Center, and value-based healthcare training at the Dartmouth Institute for Health Policy & Clinical Practice, and Minority Health Policy Fellowship at Harvard Medical School. He has a master’s in health policy and health management from Harvard University and a master’s in business administration from Columbia Business School.

Ambrose is currently exploring system-based barriers in healthcare for vulnerable and marginalized communities (e.g. Asian and Pacific Islander immigrants and refugees). He is also examining the structural and ethical factors in technological development and implementation, such as Artificial Intelligence and digital therapeutics, that may worsen health inequity in the adult, pediatric, and minority populations. He has presented his work at national and international conferences and to The President's Advisory Commission on Asian Americans, Native Hawaiians, and Pacific Islanders.